Aktien Sensor

Merck & Co Inc is facing a class action securities lawsuit alleging securities fraud from February 2022 to 2025, with the company’s stock price and future uncertain.

Merck & Co Inc is facing a class action securities lawsuit alleging securities fraud, but analysts remain bullish on the company’s prospects despite uncertainty surrounding the lawsuit’s outcome.

Merck & Co Inc navigates market turbulence amidst tariff uncertainty, with the pharmaceutical industry as a whole facing far-reaching implications.

Merck & Co Inc’s stock price has surged in recent days due to a key investment by Inge Thulin, a respected industry figure, reflecting growing confidence in the company’s prospects.